Friday, February 11, 2022

F.D.A. Authorizes Monoclonal Antibody Drug With Promise Against Omicron

The federal government has ordered 600,000 doses of the treatment, which is meant for high-risk Covid patients early in their illness.

from NYT > Top Stories https://ift.tt/nGPurbl
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

‘We Are Coming From Hell’: A Ukrainian City’s Evacuees Tell Survival Stories

Safely out of Oleshky after enduring years in the combat zone and a harrowing 24-hour journey, weary civilians reunited with family and frie...